BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 30483978)

  • 21. Characteristics of hypertrophic pachymeningitis in patients with granulomatosis with polyangiitis.
    Choi HA; Lee MJ; Chung CS
    J Neurol; 2017 Apr; 264(4):724-732. PubMed ID: 28220286
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type.
    Unizony S; Villarreal M; Miloslavsky EM; Lu N; Merkel PA; Spiera R; Seo P; Langford CA; Hoffman GS; Kallenberg CM; St Clair EW; Ikle D; Tchao NK; Ding L; Brunetta P; Choi HK; Monach PA; Fervenza F; Stone JH; Specks U;
    Ann Rheum Dis; 2016 Jun; 75(6):1166-9. PubMed ID: 26621483
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Four cases of MPO-ANCA-positive vasculitis with otitis media, and review of the literature.
    Ono N; Yoshihiro K; Oryoji D; Matsuda M; Ueki Y; Uezono S; Kai Y; Himeji D; Niiro H; Ueda A
    Mod Rheumatol; 2013 May; 23(3):554-63. PubMed ID: 22706878
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New insights into the epidemiology of ANCA-associated vasculitides in Germany: results from a claims data study.
    Hellmich B; Lamprecht P; Spearpoint P; Götte D; Deichmann A; Buchholz I; Schönermark MP; Rutherford P
    Rheumatology (Oxford); 2021 Oct; 60(10):4868-4873. PubMed ID: 33501936
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Imaging characteristics of hypertrophic pachymeningitis due to ANCA-associated vasculitis.
    Takagi T; Okada M; Nakamura M; Hanari T; Nakata T; Teraoka M; Hato N
    Auris Nasus Larynx; 2022 Oct; 49(5):875-879. PubMed ID: 35074241
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical impact of subgrouping ANCA-associated vasculitis according to antibody specificity beyond the clinicopathological classification.
    Deshayes S; Martin Silva N; Khoy K; Yameogo S; Mariotte D; Lobbedez T; Aouba A
    Rheumatology (Oxford); 2019 Oct; 58(10):1731-1739. PubMed ID: 30805643
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence and prevalence of granulomatosis with polyangiitis and microscopic polyangiitis in health management organization in Argentina: a 15-year study.
    Pierini FS; Scolnik M; Scaglioni V; Mollerach F; Soriano ER
    Clin Rheumatol; 2019 Jul; 38(7):1935-1940. PubMed ID: 30746579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Otitis media with ANCA-associated vasculitis: A retrospective study of 30 patients.
    Tabei A; Sakairi T; Ohishi Y; Watanabe M; Nakasatomi M; Hamatani H; Ikeuchi H; Kaneko Y; Hiromura K
    Mod Rheumatol; 2022 Aug; 32(5):923-929. PubMed ID: 34915561
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inflammatory bowel diseases in anti-neutrophil cytoplasmic antibody-associated vasculitides: 11 retrospective cases from the French Vasculitis Study Group.
    Humbert S; Guilpain P; Puéchal X; Terrier B; Rivière S; Mahr A; Pagnoux C; Bagnères D; Cordier JF; Le Quellec A; Altwegg R; Guillevin L;
    Rheumatology (Oxford); 2015 Nov; 54(11):1970-5. PubMed ID: 26106214
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathogenesis and diagnosis of otitis media with ANCA-associated vasculitis.
    Yoshida N; Iino Y
    Allergol Int; 2014 Dec; 63(4):523-32. PubMed ID: 25339433
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidemiology and treatment outcome of ANCA-associated vasculitis in South Korea: a nationwide, population-based cohort study.
    Park JW; Song J; Choi S; Park SJ; Park SM; Lee EY
    Clin Exp Rheumatol; 2024 Apr; 42(4):879-886. PubMed ID: 38525995
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypertrophic pachymeningitis associated with antineutrophil cytoplasmic antibody-associated vasculitis: a case series of 15 patients.
    Sakairi T; Sakurai N; Nakasatomi M; Ikeuchi H; Kaneko Y; Maeshima A; Nojima Y; Hiromura K
    Scand J Rheumatol; 2019 May; 48(3):218-224. PubMed ID: 30394816
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ANCA-associated renal vasculitis is associated with rurality but not seasonality or deprivation in a complete national cohort study.
    Aiyegbusi O; Frleta-Gilchrist M; Traynor JP; Mackinnon B; Bell S; Hunter RW; Dhaun N; Kidder D; Stewart G; Joss N; Kelly M; Shah S; Dey V; Buck K; Stevens KI; Geddes CC; McQuarrie EP;
    RMD Open; 2021 Apr; 7(2):. PubMed ID: 33875562
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence and prognostic relevance of cardiac involvement in ANCA-associated vasculitis: eosinophilic granulomatosis with polyangiitis and granulomatosis with polyangiitis.
    Hazebroek MR; Kemna MJ; Schalla S; Sanders-van Wijk S; Gerretsen SC; Dennert R; Merken J; Kuznetsova T; Staessen JA; Brunner-La Rocca HP; van Paassen P; Cohen Tervaert JW; Heymans S
    Int J Cardiol; 2015 Nov; 199():170-9. PubMed ID: 26209947
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Revisiting the classification of clinical phenotypes of anti-neutrophil cytoplasmic antibody-associated vasculitis: a cluster analysis.
    Mahr A; Katsahian S; Varet H; Guillevin L; Hagen EC; Höglund P; Merkel PA; Pagnoux C; Rasmussen N; Westman K; Jayne DR;
    Ann Rheum Dis; 2013 Jun; 72(6):1003-10. PubMed ID: 22962314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peripheral neuropathy in antineutrophil cytoplasmic antibody-associated vasculitides: Insights from the DCVAS study.
    Bischof A; Jaeger VK; Hadden RDM; Luqmani RA; Pröbstel AK; Merkel PA; Suppiah R; Craven A; Collins MP; Daikeler T
    Neurol Neuroimmunol Neuroinflamm; 2019 Nov; 6(6):. PubMed ID: 31540965
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical Effect of Alpha-1 Antitrypsin Deficiency in Antineutrophil Cytoplasmic Antibody-associated Vasculitis: Results from a French Retrospective Monocentric Cohort.
    Deshayes S; Martin Silva N; Grandhomme F; Khoy K; Mariotte D; Boutemy J; Maigné G; Brière-Bellier C; Delmas C; Bienvenu B; Lobbedez T; de Boysson H; Aouba A
    J Rheumatol; 2019 Nov; 46(11):1502-1508. PubMed ID: 30824651
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence of Malignancy Prior to Antineutrophil Cytoplasmic Antibody-associated Vasculitis Compared to the General Population.
    van Daalen EE; Rahmattulla C; Wolterbeek R; Bruijn JA; Bajema IM
    J Rheumatol; 2017 Mar; 44(3):314-318. PubMed ID: 28089971
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cancer development in Korean patients with ANCA-associated vasculitis: a single centre study.
    Yoo J; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
    Clin Exp Rheumatol; 2018; 36 Suppl 111(2):73-77. PubMed ID: 29465366
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development and validation of case-finding algorithms for the identification of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis in large healthcare administrative databases.
    Sreih AG; Annapureddy N; Springer J; Casey G; Byram K; Cruz A; Estephan M; Frangiosa V; George MD; Liu M; Parker A; Sangani S; Sharim R; Merkel PA;
    Pharmacoepidemiol Drug Saf; 2016 Dec; 25(12):1368-1374. PubMed ID: 27804171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.